Merck shares slide premarket as Pfizer soars on data from trial of rival COVID antiviral treatmentMarket Watch • 11/05/21
Merck's Covid pill approved by UK regulator, a potential game-changer in fighting the pandemicCNBC • 11/04/21
Merck and Ridgeback's Molnupiravir, an Oral COVID-19 Antiviral Medicine, Receives First Authorization in the WorldBusiness Wire • 11/04/21
Monday Afternoon Analyst Upgrades and Downgrades: Bristol-Myers, Intel, Merck, Newell, Snap and More24/7 Wall Street • 11/01/21
5 Big Dividend Biotech and Pharmaceutical Stocks Have Strong Upside Potential24/7 Wall Street • 11/01/21
New Research for KEYTRUDA® (pembrolizumab) at Society for Melanoma Research (SMR) 2021 Congress Reinforces Merck's Commitment to Patients With Melanoma Across Stages of DiseaseBusiness Wire • 10/31/21